Long-term L-Carnitine Administration reduces Erythropoietin Resistance in Chronic Hemodialysis Patients with Thalassemia Minor

Long-term L-Carnitine Administration reduces Erythropoietin Resistance in Chronic Hemodialysis Patients with Thalassemia Minor

Background and Aim Both thalassemia and carnitine deficiency represent independent causes of erythropoietin resistance, and thus anemia, in uremic patients. We evaluated the unknown long-term effects of L-carnitine administration in β-thalassemic on chronic hemodialysis. Methods We studied twelve su...

Full description

Bibliographic Details
Main Authors: Biagio R. Di Iorio, Pasquale Guastaferro, Nicola Cillo, Emanuele Cucciniello, Vincenzo Bellizzi
Format: Article
Language:English
Published: AboutScience Srl 2007-01-01
Series:Drug Target Insights
Online Access:https://doi.org/10.1177/117739280700200001

Similar Items

Similar Items